undamentalytics Newsletter
Sign in

Balchem Corp key statistics and ratios

In fiscal 2025, Balchem Corp had return on equity of 12.9% and a net margin of 14.9%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Net margin12.2%13.0%13.3%12.9%13.3%9.8%10.8%10.1%15.1%12.2%12.4%12.0%12.0%11.2%11.8%13.5%14.9%15.4%
Return on equity18.2%19.9%18.5%15.8%14.8%14.6%14.0%11.4%15.8%12.0%11.1%10.8%11.3%11.6%10.9%11.7%12.9%13.2%
Return on assets14.3%16.0%15.5%13.7%13.0%8.5%6.9%6.1%9.4%8.1%7.5%7.3%8.1%7.5%6.7%8.1%9.5%10.1%
Effective tax rate34.0%33.6%31.7%33.2%31.8%31.4%31.4%32.5%−1.8%20.7%17.4%20.5%23.3%21.2%20.9%22.8%22.2%22.5%
R&D as % of revenue1.5%1.3%1.0%1.1%1.1%0.9%1.1%1.3%1.6%1.8%1.8%1.5%1.7%1.3%1.6%1.8%1.8%1.9%
SG&A as % of revenue—————0.5%0.5%———————————
Dividends ÷ net income7.5%9.3%11.1%29.3%0.0%14.9%15.5%19.2%13.4%17.1%19.0%19.7%19.5%19.7%21.1%19.9%18.3%18.0%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 2 checks passed · September 30, 2026
What it owns · $1.7bn
Short-term assets $405mLonger-term assets $1.3bn
What it owes, and who funded it · $1.7bn
Short-term liabilities $164mLonger-term liabilities $213mShareholders' equity $1.3bn
  • Short-term assets cover short-term liabilities $405m of assets due within a year against $164m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $405m short-term assets against $213m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Balchem Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

72 /100

Strong moat

How hard Balchem's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 11 / 20

    Net income has been a median 7.4% of total assets over 10 years.

  • Pricing power 12 / 20

    Gross margin has been a median 32.1%, moving by 2.0 percentage points (standard deviation) across 10 years.

  • Durability 15 / 20

    Operating margin has been a median 16.6%; its worst year was 15.4%.

  • Cash conversion 18 / 20

    Free cash flow was positive in 10 of 10 years, at a median 15.5% of revenue.

  • Discipline 17 / 20

    The diluted share count fell 1.2% over five years; stock-based pay has been a median 1.3% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: BCPC vs HWKNALTO vs BCPCBCPC vs ECVTBCPC vs PRM

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Balchem Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Balchem Corp.